Results 171 to 180 of about 2,088,860 (358)

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

PROTECTION AGAINST ACUTE, ASCENDING PYELONEPHRITIS CAUSED BY E.COLI IN RATS USING ISOLATED CAPSULAR ANTIGEN CONJUGATED TO A CARRIER SUBSTANCE [PDF]

, 1980
B. Kaijser, Per Larsson, Rachel Schneerson   +2 more
openalex   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

BIOCHEMICAL OBSERVATIONS FOR THE USE OF SEVERAL SUBSTANCES ON THE TREATMENT OF HEPATIC COMA

, 1959
Takashi Suzuki
openalex   +2 more sources

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Dog ownership for people with substance use disorder: self-reported influence on substance use and mental health. [PDF]

Subst Abuse Treat Prev Policy
Kerr-Little A, Bramness JG, Newberry RC, Biong S.   +3 more
europepmc   +1 more source

Studies on Carcinostatic Substances. XL. Application of Cell Counting Method to the Screening of Antitumor Substances using the in vitro-cultured Yoshida Sarcoma Cells.

, 1962
Ayako Moriwaki
openalex   +2 more sources

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Changes in the trajectories of drug-free friendships and substance use among a cohort of individuals with multiple substance use disorders. [PDF]

Nordisk Alkohol Nark
Moe FD, Tjora T, Moltu C, McKay JR, Hagen E, Erga A, Bjornestad J.   +6 more
europepmc   +1 more source

Adsorption gas chromatography using water vapor as the carrier gas for organic substances containing oxygen

, 1967
Akira Nonaka
openalex   +2 more sources